Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

ATLANTIC EPIPHYTES: a data set of vascular and non-vascular epiphyte plants and lichens from the Atlantic Forest.

Ramos FN, Mortara SR, Monalisa-Francisco N, Elias JPC, Neto LM, Freitas L, Kersten R, Amorim AM, Matos FB, Nunes-Freitas AF, Alcantara S, Alexandre MHN, de Almeida-Scabbia RJ, de Almeida OJG, Alves FE, de Oliveira Alves RM, Alvim FS, de Andrade ACS, de Andrade S, Aona LYS, Araujo AC, de Araújo KCT, Ariati V, Assis JC, de Azevedo CO, Barbosa BF, Barbosa DEF, Barbosa FDR, de Barros F, Basilio GA, Bataghin FA, Bered F, Bianchi JS, Blum CT, Boelter CR, Bonnet A, Brancalion PHS, Breier TB, Brion CT, Buzatto CR, Cabral A, Cadorin TJ, Caglioni E, Canêz L, Cardoso PH, de Carvalho FS, Carvalho RG, Catharino ELM, Ceballos SJ, Cerezini MT, César RG, Cestari C, Chaves CJN, Citadini-Zanette V, Coelho LFM, Coffani-Nunes JV, Colares R, Colletta GD, Corrêa NM, da Costa AF, da Costa GM, Costa LMS, Costa NGS, Couto DR, Cristofolini C, da Cruz ACR, Del Neri LA, di Pasquo M, Dos Santos Dias A, Dias LDCD, Dislich R, Duarte MC, Fabricante JR, Farache FHA, de Faria APG, Faxina C, Ferreira MTM, Fischer E, Fonseca CR, Fontoura T, Francisco TM, Furtado SG, Galetti M, Garbin ML, de Gasper AL, Goetze M, Gomes-da-Silva J, Gonçalves MFA, Gonzaga DR, Silva ACGE, Guaraldo AC, Guarino ESG, Guislon AV, Hudson LB, Jardim JG, Jungbluth P, Kaeser SDS, Kessous IM, Koch NM, Kuniyoshi YS, Labiak PH, Lapate ME, Santos ACL, Leal RLB, Leite FS, Leitman P, Liboni AP, Liebsch D, Lingner DV, Lombardi JA, Lucas E, Luzzi JDR, Mai P, Mania LF, Mantovani W, Maragni AG, Marques MCM, Marquez G, Martins C, Martins LDN, Martins PLSS, Mazziero FFF, Melo CA, de Melo MMF, Mendes AF, Mesacasa L, Morellato LPC, Moreno VS, Muller A, Murakami MMDS, Cecconello E, Nardy C, Nervo MH, Neves B, Nogueira MGC, Nonato FR, de Oliveira-Filho AT, de Oliveira CPL, Overbeck GE, Marcusso GM, Paciencia MLB, Padilha P, Padilha PT, Pereira ACA, Pereira LC, Pereira RAS, Pincheira-Ulbrich J, Pires JSR, Pizo MA, Pôrto KC, Rattis L, Reis JRM, Reis SGD, da Rocha-Pessôa TC, Rocha CFD, Rocha FS, Rodrigues ARP, Rodrigues RR, Rogalski JM, Rosanelli RL, Rossado A, Rossatto DR, Rother DC, Ruiz-Miranda CR, Saiter FZ, Sampaio MB, Santana LD, Santos JSD, Sartorello R, Sazima M, Schmitt JL, Schneider G, Schroeder BG, Sevegnani L, Júnior VOS, da Silva FR, da Silva MJ, Silva MPP, Silva RG, Silva SM, Singer RB, Siqueira G, Soares LE, de Sousa HC, Spielmann A, Tonetti VR, Toniato MTZ, Ulguim PSB, van den Berg C, van den Berg E, Varassin IG, da Silva IBV, Vibrans AC, Waechter JL, Weissenberg EW, Windisch PG, Wolowski M, Yañez A, Yoshikawa VN, Zandoná LR, Zanella CM, Zanin EM, Zappi DC, Zipparro VB, Zorzanelli JPF, Ribeiro MC.

Ecology. 2019 Feb;100(2):e02541. doi: 10.1002/ecy.2541.

PMID:
30707454
2.

Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.

Sandoval Y, Smith SW, Schulz KM, Murakami MM, Love SA, Nicholson J, Apple FS.

Clin Chem. 2015 Apr;61(4):657-63. doi: 10.1373/clinchem.2014.236638. Epub 2015 Feb 11.

3.

Electronic medical record-based performance improvement project to document and reduce excessive cardiac troponin testing.

Love SA, McKinney ZJ, Sandoval Y, Smith SW, Kohler R, Murakami MM, Apple FS.

Clin Chem. 2015 Mar;61(3):498-504. doi: 10.1373/clinchem.2014.234310. Epub 2014 Dec 23.

4.

Cardiac troponin testing is overused after the rule-in or rule-out of myocardial infarction.

Fraga OR, Sandoval Y, Love SA, McKinney ZJ, Murakami MM, Smith SW, Apple FS.

Clin Chem. 2015 Feb;61(2):436-8. doi: 10.1373/clinchem.2014.232694. Epub 2014 Nov 11. No abstract available.

5.

Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk.

Sandoval Y, Thordsen SE, Smith SW, Schulz KM, Murakami MM, Pearce LA, Apple FS.

Eur Heart J Acute Cardiovasc Care. 2014 Dec;3(4):317-25. doi: 10.1177/2048872614538411. Epub 2014 Jun 25.

PMID:
24965188
6.

Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction.

Palamalai V, Murakami MM, Apple FS.

Clin Biochem. 2013 Nov;46(16-17):1631-5. doi: 10.1016/j.clinbiochem.2013.06.026. Epub 2013 Jul 11.

PMID:
23850852
7.

Performance characteristics of the ARCHITECT Galectin-3 assay.

La'ulu SL, Apple FS, Murakami MM, Ler R, Roberts WL, Straseski JA.

Clin Biochem. 2013 Jan;46(1-2):119-22. doi: 10.1016/j.clinbiochem.2012.09.014. Epub 2012 Sep 23.

PMID:
23010446
8.

Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population.

Apple FS, Ler R, Murakami MM.

Clin Chem. 2012 Nov;58(11):1574-81. doi: 10.1373/clinchem.2012.192716. Epub 2012 Sep 14.

9.

Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay.

Apple FS, Smith SW, Pearce LA, Murakami MM.

Clin Biochem. 2012 Jul;45(10-11):711-3. doi: 10.1016/j.clinbiochem.2012.02.030. Epub 2012 Mar 23.

PMID:
22465126
10.

Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey.

Apple FS, Steffen LM, Pearce LA, Murakami MM, Luepker RV.

Clin Chem. 2012 May;58(5):930-5. doi: 10.1373/clinchem.2011.179176. Epub 2012 Mar 19.

11.

N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia.

Postnikov AB, Smolyanova TI, Kharitonov AV, Serebryanaya DV, Kozlovsky SV, Tryshina YA, Malanicev RV, Arutyunov AG, Murakami MM, Apple FS, Katrukha AG.

Clin Biochem. 2012 May;45(7-8):519-24. doi: 10.1016/j.clinbiochem.2011.12.030. Epub 2012 Jan 28.

PMID:
22306170
12.

Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations.

Apple FS, Smith SW, Pearce LA, Schulz KM, Ler R, Murakami MM.

Clin Chem. 2011 Apr;57(4):603-8. doi: 10.1373/clinchem.2010.158014. Epub 2011 Jan 24.

13.

Measurement of B-type natriuretic peptide by two assays utilizing antibodies with different epitope specificity.

Tamm NN, Semenov AG, Seferian KR, Bereznikova AV, Murakami MM, Apple FS, Koshkina EV, Krasnoselsky MI, Katrukha AG.

Clin Biochem. 2011 Feb;44(2-3):257-9. doi: 10.1016/j.clinbiochem.2010.09.030. Epub 2010 Oct 13.

PMID:
20950595
14.

Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay.

Apple FS, Simpson PA, Murakami MM.

Clin Biochem. 2010 Aug;43(12):1034-6. doi: 10.1016/j.clinbiochem.2010.05.014. Epub 2010 May 27.

PMID:
20510894
15.

Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events.

Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM.

Clin Chem. 2009 May;55(5):930-7. doi: 10.1373/clinchem.2008.114728. Epub 2009 Mar 19.

16.

Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome.

Apple FS, Smith SW, Pearce LA, Murakami MM.

Clin Chem. 2009 Jan;55(1):93-100. doi: 10.1373/clinchem.2008.102905. Epub 2008 Nov 21.

17.

Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injury.

Apple FS, Murakami MM, Ler R, Walker D, York M; HESI Technical Committee of Biomarkers Working Group on Cardiac Troponins.

Clin Chem. 2008 Dec;54(12):1982-9. doi: 10.1373/clinchem.2007.097568. Epub 2008 Oct 9.

18.

Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood.

Tamm NN, Seferian KR, Semenov AG, Mukharyamova KS, Koshkina EV, Krasnoselsky MI, Postnikov AB, Serebryanaya DV, Apple FS, Murakami MM, Katrukha AG.

Clin Chem. 2008 Sep;54(9):1511-8. doi: 10.1373/clinchem.2007.100545. Epub 2008 Jul 7.

19.

Immunodetection of glycosylated NT-proBNP circulating in human blood.

Seferian KR, Tamm NN, Semenov AG, Tolstaya AA, Koshkina EV, Krasnoselsky MI, Postnikov AB, Serebryanaya DV, Apple FS, Murakami MM, Katrukha AG.

Clin Chem. 2008 May;54(5):866-73. doi: 10.1373/clinchem.2007.100040. Epub 2008 Mar 13.

20.

Performance characteristics of the Architect brain natriuretic peptide (BNP) assay: a two site study.

Mongia SK, La'ulu SL, Apple FS, Ler R, Murakami MM, Roberts WL.

Clin Chim Acta. 2008 May;391(1-2):102-5. doi: 10.1016/j.cca.2008.01.026. Epub 2008 Feb 12.

PMID:
18294456
21.

Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.

Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM.

Clin Chem. 2008 Apr;54(4):723-8. doi: 10.1373/clinchem.2007.097162. Epub 2008 Jan 31.

22.

Use of the bioMérieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.

Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM, Benoit MO, Levy C, Dumas C, Paul JL.

Clin Chim Acta. 2008 Apr;390(1-2):72-5. doi: 10.1016/j.cca.2007.12.016. Epub 2008 Jan 11.

PMID:
18230357
23.

Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.

Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H, Breit SN.

Nat Med. 2007 Nov;13(11):1333-40. Epub 2007 Nov 4.

PMID:
17982462
24.

Analytical and clinical performance of the Ortho-Clinical Diagnostics VITROS amino-terminal pro-B type natriuretic peptide assay.

Januzzi JL Jr, Lewandrowski KB, Bashirians G, Jackson S, Freyler D, Smith K, Murakami MM, Apple FS.

Clin Chim Acta. 2008 Jan;387(1-2):48-54. Epub 2007 Sep 8.

PMID:
17915201
25.

Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.

Lee-Lewandrowski E, Januzzi JL, Green SM, Tannous B, Wu AH, Smith A, Wong A, Murakami MM, Kaczmarek J, Apple FS, Miller WL, Hartman K, Jaffe AS.

Clin Chim Acta. 2007 Nov-Dec;386(1-2):20-4. Epub 2007 Jul 25.

PMID:
17854790
26.

Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays.

Apple FS, Murakami MM.

Clin Chem. 2007 Aug;53(8):1558-60. No abstract available.

27.

Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.

Apple FS, Pearce LA, Chung A, Ler R, Murakami MM.

Clin Chem. 2007 May;53(5):874-81. Epub 2007 Mar 23.

29.

Cationic latex formation by ionic modification.

Schumacher HC, Alves M, Leite CA, Santos JP, Neto ET, Murakami MM, Galembeck F, do Amaral M.

J Colloid Interface Sci. 2007 Jan 15;305(2):256-63. Epub 2006 Oct 25.

PMID:
17067613
30.
31.
32.

Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome.

Apple FS, Ler R, Chung AY, Berger MJ, Murakami MM.

Clin Chem. 2006 Feb;52(2):322-5.

33.

The diagnostic utility of cardiac biomarkers in detecting myocardial infarction.

Apple FS, Murakami MM.

Clin Cornerstone. 2005;7 Suppl 1:S25-30.

PMID:
15899366
34.

Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction.

Apple FS, Murakami MM.

Clin Chem. 2005 Feb;51(2):460-3. Epub 2004 Nov 24. No abstract available.

36.

Serum 99th percentile reference cutoffs for seven cardiac troponin assays.

Apple FS, Murakami MM.

Clin Chem. 2004 Aug;50(8):1477-9. No abstract available.

37.

Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.

Wu AH, Smith A, Christenson RH, Murakami MM, Apple FS.

Clin Chim Acta. 2004 Aug 16;346(2):211-9. Erratum in: Clin Chim Acta. 2005 May;355(1-2):219.

PMID:
15256323
38.

Analytical performance of the i-STAT cardiac troponin I assay.

Apple FS, Murakami MM, Christenson RH, Campbell JL, Miller CJ, Hock KG, Scott MG.

Clin Chim Acta. 2004 Jul;345(1-2):123-7.

PMID:
15193986
39.
40.

Measurement of chemical analytes in vitreous humor: stability and precision studies.

Gagajewski A, Murakami MM, Kloss J, Edstrom M, Hillyer M, Peterson GF, Amatuzio J, Apple FS.

J Forensic Sci. 2004 Mar;49(2):371-4.

PMID:
15027563
41.

Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes.

Lin JC, Apple FS, Murakami MM, Luepker RV.

Clin Chem. 2004 Feb;50(2):333-8. Epub 2003 Dec 11.

44.

Operationalizing cardiac troponin I testing along ESC/ACC consensus guidelines for defining myocardial infarction: increasing rate of detection.

Apple FS, Johari V, Hoybook KJ, Weber-Shrikant E, Davis GK, Murakami MM.

Clin Chim Acta. 2003 May;331(1-2):165-6. No abstract available.

PMID:
12691878
45.

Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease.

Apple FS, Murakami MM, Pearce LA, Herzog CA.

Circulation. 2002 Dec 3;106(23):2941-5.

PMID:
12460876
46.

Near-bedside whole-blood cardiac troponin I assay for risk assessment of patients with acute coronary syndromes.

Apple FS, Murakami MM, Jesse RL, Levitt MA, Berger AK, Pearce LA, Collinson P.

Clin Chem. 2002 Oct;48(10):1784-7. No abstract available.

47.

Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race.

Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM.

Clin Chem. 2002 Jul;48(7):1097-100. No abstract available.

48.

Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction.

Apple FS, Anderson FP, Collinson P, Jesse RL, Kontos MC, Levitt MA, Miller EA, Murakami MM.

Clin Chem. 2000 Oct;46(10):1604-9.

49.

Preliminary evaluation of the Vitros ECi cardiac troponin I assay.

Apple FS, Koplen B, Murakami MM.

Clin Chem. 2000 Apr;46(4):572-4. No abstract available.

PMID:
10759486
50.

Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency.

McLaurin MD, Apple FS, Falahati A, Murakami MM, Miller EA, Sharkey SW.

Am J Cardiol. 1998 Oct 15;82(8):973-5.

PMID:
9794355

Supplemental Content

Loading ...
Support Center